Cargando…

Identifying the associated risks of pneumonia in COPD patients: ARCTIC an observational study

BACKGROUND: Inhaled corticosteroids (ICS) are associated with an increased risk of pneumonia in patients with chronic obstructive pulmonary disease (COPD). Other factors such as severity of airflow limitation and concurrent asthma may further raise the possibility of developing pneumonia. This study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Janson, Christer, Johansson, Gunnar, Ställberg, Björn, Lisspers, Karin, Olsson, Petter, Keininger, Dorothy L., Uhde, Milica, Gutzwiller, Florian S., Jörgensen, Leif, Larsson, Kjell
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131919/ https://www.ncbi.nlm.nih.gov/pubmed/30200965 http://dx.doi.org/10.1186/s12931-018-0868-y

Ejemplares similares

Impact of COPD diagnosis timing on clinical and economic outcomes: the ARCTIC observational cohort study
por: Larsson, Kjell, et al.
Publicado: (2019)

Economic burden of COPD in a Swedish cohort: the ARCTIC study
por: Lisspers, Karin, et al.
Publicado: (2018)

Real-world retrospective cohort study ARCTIC shows burden of comorbidities in Swedish COPD versus non-COPD patients
por: Ställberg, Björn, et al.
Publicado: (2018)

The Impact of Exacerbation Frequency on Clinical and Economic Outcomes in Swedish COPD Patients: The ARCTIC Study
por: Larsson, Kjell, et al.
Publicado: (2021)

Gender differences among Swedish COPD patients: results from the ARCTIC, a real-world retrospective cohort study
por: Lisspers, Karin, et al.
Publicado: (2019)

Treatment Patterns, Socioeconomic Status and Clinical Burden in Mild COPD: A Swedish Real-World, Retrospective Cohort Study, the ARCTIC Study
por: Larsson, Kjell, et al.
Publicado: (2022)

Pneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting β(2) agonist: observational matched cohort study (PATHOS)
por: Janson, Christer, et al.
Publicado: (2013)

Inhaled corticosteroids and the risk of type 2 diabetes among Swedish COPD patients
por: Ställberg, Björn, et al.
Publicado: (2020)

Predicting Hospitalization Due to COPD Exacerbations in Swedish Primary Care Patients Using Machine Learning – Based on the ARCTIC Study
por: Ställberg, Björn, et al.
Publicado: (2021)

Factors associated with lung cancer in COPD patients
por: Sandelin, Martin, et al.
Publicado: (2018)

Management, morbidity and mortality of COPD during an 11-year period: an observational retrospective epidemiological register study in Sweden (PATHOS)
por: Ställberg, Björn, et al.
Publicado: (2014)

Impact of Comorbidities and Commonly Used Drugs on Mortality in COPD – Real-World Data from a Primary Care Setting
por: Ellingsen, Jens, et al.
Publicado: (2020)

Prevalence, characteristics and management of frequently exacerbating asthma patients: an observational study in Sweden (PACEHR)
por: Janson, Christer, et al.
Publicado: (2018)

Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR)
por: Larsson, Kjell, et al.
Publicado: (2018)

Clinical COPD Questionnaire score (CCQ) and mortality
por: Sundh, Josefin, et al.
Publicado: (2012)

Health care resource utilization and cost for asthma patients regularly treated with oral corticosteroids – a Swedish observational cohort study (PACEHR)
por: Janson, Christer, et al.
Publicado: (2018)

Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD: FLAME-based modelling in a Swedish population
por: Bjermer, Leif, et al.
Publicado: (2017)

Factors influencing pharmacological treatment in COPD: a comparison of 2005 and 2014
por: Sundh, Josefin, et al.
Publicado: (2017)

Pulmonary rehabilitation in COPD – available resources and utilization in Swedish primary and secondary care
por: Sundh, Josefin, et al.
Publicado: (2017)

Neutrophil-to-lymphocyte ratio, blood eosinophils and COPD exacerbations: a cohort study
por: Ellingsen, Jens, et al.
Publicado: (2021)

Change in health status in COPD: a seven-year follow-up cohort study
por: Sundh, Josefin, et al.
Publicado: (2016)

Influence of comorbid heart disease on dyspnea and health status in patients with COPD – a cohort study
por: Giezeman, Maaike, et al.
Publicado: (2018)

Subjective swallowing symptoms and related risk factors in COPD
por: Gonzalez Lindh, Margareta, et al.
Publicado: (2019)

Changes in smoking prevalence and cessation support, and factors associated with successful smoking cessation in Swedish patients with asthma and COPD
por: Stegberg, Marcus, et al.
Publicado: (2018)

Prediction of Mortality Using Different COPD Risk Assessments – A 12-Year Follow-Up
por: Athlin, Åsa, et al.
Publicado: (2021)

2017 Global Initiative for Chronic Obstructive Lung Disease reclassifies half of COPD subjects to lower risk group
por: Högman, Marieann, et al.
Publicado: (2018)

MAIT cell counts are associated with the risk of hospitalization in COPD
por: Pincikova, Terezia, et al.
Publicado: (2022)

Does multimorbidity result in de-prioritisation of COPD in primary care?
por: Smith, Carolina, et al.
Publicado: (2023)

Critical inhaler technique errors in Swedish patients with COPD: a cross-sectional study analysing video-recorded demonstrations
por: Sulku, Johanna, et al.
Publicado: (2021)

Determinants of uncontrolled asthma in a Swedish asthma population: cross-sectional observational study
por: Kämpe, Mary, et al.
Publicado: (2014)

Assessment of COPD in primary care: new evidence supports use of the DOSE index
por: Sundh, Josefin, et al.
Publicado: (2013)

Real-world evidence effect of budesonide+formoterol Spiromax on patients with asthma and chronic obstructive pulmonary disease in Sweden
por: Janson, Christer, et al.
Publicado: (2019)

Diagnostic spirometry in COPD is increasing, a comparison of two Swedish cohorts
por: Athlin, Åsa, et al.
Publicado: (2023)

Characterization of secondary care for COPD in Sweden
por: Sundh, Josefin, et al.
Publicado: (2017)

A Cross-Sectional Study Assessing Appropriateness Of Inhaled Corticosteroid Treatment In Primary And Secondary Care Patients With COPD In Sweden
por: Sulku, Johanna, et al.
Publicado: (2019)

Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD
por: Janson, Christer, et al.
Publicado: (2017)

Availability of pulmonary rehabilitation in primary care for patients with COPD: a cross-sectional study in Sweden
por: Arne, Mats, et al.
Publicado: (2016)

Comorbid Heart Disease in Patients with COPD is Associated with Increased Hospitalization and Mortality – A 15-Year Follow-Up
por: Giezeman, Maaike, et al.
Publicado: (2023)

Sex-related differences in management of Swedish patients with a clinical diagnosis of chronic obstructive pulmonary disease
por: Åberg, Joakim, et al.
Publicado: (2019)

Factors associated with well‐controlled asthma—A cross‐sectional study
por: Lindgren, Helena, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4gf69pe6s3h8hcare1f793s023